- ADVM Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Adverum Biotechnologies (ADVM) S-3Shelf registration
Filed: 10 Aug 17, 12:00am
Exhibit 12.1
STATEMENT OF COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(dollars in thousands)
Six Months | Year Ended December 31, | |||||||||||||||
Ended June 30, | ||||||||||||||||
2017 | 2016 | 2015 | 2014 | |||||||||||||
Fixed charges: | ||||||||||||||||
Interest expense on indebtedness | $ | 13 | $ | 25 | $ | 14 | $ | 0 | ||||||||
Interest expense on portion of rent expense representative of interest | $ | 62 | 122 | 92 | 18 | |||||||||||
|
|
|
|
|
|
|
| |||||||||
Total fixed charges | $ | 75 | $ | 147 | $ | 106 | $ | 18 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Preferred stock deemed dividend | $ | 0 | $ | 0 | $ | 0 | $ | 3,230 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Total fixed charges and preferred dividend | $ | 75 | $ | 147 | $ | 106 | $ | 3,248 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Net loss | (27,529 | ) | (114,522 | ) | (47,453 | ) | (25,404 | ) | ||||||||
Fixed charges per above | 75 | 147 | 106 | 18 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Total earnings (loss) | (27,454 | ) | (114,375 | ) | (47,347 | ) | (25,386 | ) | ||||||||
|
|
|
|
|
|
|
| |||||||||
Ratio of earnings to fixed charges | N/A | N/A | N/A | N/A | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Deficiency of earnings available to cover fixed charges | (27,529 | ) | (114,522 | ) | (47,453 | ) | (28,634 | ) |